Genetic studies in Alzheimer's disease with an NACP/α-synuclein polymorphism

105Citations
Citations of this article
52Readers
Mendeley users who have this article in their library.

Abstract

The non-Aβ component of Alzheimer's disease amyloid (NAC) is copurified with amyloid from the brain tissue of Alzheimer's disease victims and is immunohistochemically localized to amyloid fibrils. NAC is a hydrophobic peptide fragment from the NAC precursor protein (NACP/α-synuclein) that is localized to presynaptic terminals. We used a polymorphic dinucleotide repeat sequence in a genomic clone of NACP for genetic association and linkage studies. Screening of Alzheimer's disease families failed to establish linkage between NACP and Alzheimer's disease. Nevertheless, one of the NACP polymorphisms (NACP allele 2) was shown to have significant association with healthy elderly control individuals with apolipoprotein E risk. This may indicate a possible protective function of the allele.

Cite

CITATION STYLE

APA

Xia, Y., De Rohan Suva, H. A., Rosi, B. L., Yamaoka, L. H., Rimmler, J. B., Pericak-Vance, M. A., … Saitoh, T. (1996). Genetic studies in Alzheimer’s disease with an NACP/α-synuclein polymorphism. Annals of Neurology, 40(2), 207–215. https://doi.org/10.1002/ana.410400212

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free